Venture-Backed Startups

0 investors

Endless Studios is a game-making studio and learning hub that teaches youth coding, design, engineering, and game development through immersive educational programs. The company partners with schools and organizations globally to build digital skills and prepare young people for careers in tech and creative industries.

1 investor

Endless West produces spirits using scientific flavor recreation methods, combining natural ingredients to replicate premium beverages while reducing production waste. The company targets consumers seeking fine spirits with improved sustainability practices.

5 investors

Endless Clouds is a mobile game studio developing an MMORPG called Treeverse, incorporating Web3 technology into gaming. The company operates with a distributed team across multiple countries.

2 investors

THIC is an alternative chocolate made from upcycled ingredients including brewer's spent grain and cacao shells, designed for both consumer and industrial baking applications. The product contains no palm oil or additives.

2 investors

Endlyz develops small-molecule disease-modifying therapeutics targeting the ATP13A2 and ATP10B lysosomal transporters to restore endo-lysosomal function and counter neurodegeneration. Its initial focus is genetic subsets of Parkinson's disease, with plans to expand into sporadic Parkinson's and other dementias.

1 investor

Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care. Par Health develops generic pharmaceuticals, sterile injectables, and active pharmaceutical ingredients with U.S.-based manufacturing capabilities.

1 investor

Endo GI Medical develops medical devices for plastic stent delivery in biliary and pancreatic duct procedures, enabling drainage through a single cannulation while maintaining guidewire position. The company's systems have received FDA clearance and are used in interventional endoscopy procedures.

1 investor

0 investors

0 investors

0 investors

0 investors

0 investors

Novartis is a pharmaceutical company developing breakthrough medicines across therapeutic areas including oncology and cardiovascular disease.

1 investor

Endodiag develops non-invasive diagnostic tests based on blood biomarkers to identify endometriosis in women, addressing a condition currently requiring surgical diagnosis. The company also creates solutions to map patient disease for personalized treatment and fertility management.

1 investor

EndoDNA + BIOS is a precision health intelligence platform for licensed healthcare practitioners that integrates genomic analysis, biomarkers, lifestyle data, and machine learning into a clinical decision-support system. The platform combines DNA sequencing with an AI reasoning engine to generate unlimited personalized wellness reports and treatment recommendations from a single patient DNA sample.

1 investor

Endodontic Practice Partners (EPP) is a dental support organization that partners with endodontic practices, providing shared business resources, infrastructure, technology, and operational support to help them grow. It serves independent endodontists across the United States, focusing on clinical, professional, and financial support.

1 investor

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.

5 investors

0 investors

Endogene is a biotech company focused on uterine biology, developing tools to improve the understanding, diagnosis, and treatment of uterine diseases.

2 investors

Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes. Developed in partnership with Mayo Clinic, the therapy aims to help patients manage blood glucose levels and slow disease progression.

4 investors

Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite. Its work spans therapeutic and dermocosmetic applications.

1 investor

Endolith develops biological intelligence technology for mineral recovery, using microbiology and AI to extract critical minerals sustainably. The company serves mining operations and the clean energy supply chain.

5 investors

0 investors